Liver abscess in advanced hepatocellular carcinoma after sorafenib treatment.
- Authors
- 신승각; 정영걸; 윤현화; 권오상; 김연수; 최덕주; 김주현
- Issue Date
- Jan-2014
- Publisher
- 대한소화기학회
- Keywords
- Sorafenib; Hepatocellular carcinoma; Liver abscess
- Citation
- The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, v.63, no.1, pp.47 - 50
- Journal Title
- The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
- Volume
- 63
- Number
- 1
- Start Page
- 47
- End Page
- 50
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12911
- DOI
- 10.4166/kjg.2014.63.1.47
- ISSN
- 1598-9992
- Abstract
- Hepatocellular carcinoma (HCC) is a critical global health issue and the third most common cause of cancer-related deaths worldwide. The majority of patients who present HCC are already at an advanced stage and their tumors are unresectable. Sorafenib is a multi-kinase inhibitor of the vascular endothelial growth factor pathway and was recently introduced as a therapy for advanced HCC. Furthermore, studies have shown that oral sorafenib has beneficial effects on survival. However, many patients experience diverse side effects, and some of these are severe. Liver abscess development has not been previously documented to be associated with sorafenib administration in HCC. Here, we report the case of a HCC patient that developed a liver abscess while being treated with sorafenib.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.